AB 632
10 links on this map: who funds them, what they touched, and who lobbied on it. Select anyone to move the map to them.
Start with
and connect to
Browse all held record sources
Zoom to read. Drag to explore. Select a connection.
Every link on this map
The same connections as a table, with the reason each one is here.
| Mike Gipson | Sponsors | Mike Gipson sponsored AB 632. | None |
| Astellas Pharma US, Inc. | Lobbied on it | Astellas Pharma US, Inc. named AB 632 in 3 lobbying reports. | 3 reports |
| California Chronic Care Coalition | Lobbied on it | California Chronic Care Coalition named AB 632 in 3 lobbying reports. | 3 reports |
| Pfizer Inc. | Lobbied on it | Pfizer Inc. named AB 632 in 3 lobbying reports. | 3 reports |
| Astrazeneca Pharmaceuticals, LP | Lobbied on it | Astrazeneca Pharmaceuticals, LP named AB 632 in 2 lobbying reports. | 2 reports |
| Axon Enterprise, Inc. | Lobbied on it | Axon Enterprise, Inc. named AB 632 in 2 lobbying reports. | 2 reports |
| American Legion, Department of California | Lobbied on it | American Legion, Department of California named AB 632 in 1 lobbying report. | 1 report |
| Amvets, Department of California | Lobbied on it | Amvets, Department of California named AB 632 in 1 lobbying report. | 1 report |
| Bayer U.S. LLC | Lobbied on it | Bayer U.S. LLC named AB 632 in 1 lobbying report. | 1 report |
| Health care coverage: prostate cancer screening. | Source records | AB 632 has an explicit source reference to Health care coverage: prostate cancer screening.. | None |
In the news
Reporting about the selected subject. Articles are context and do not establish a connection on this map.
Loading coverage…